Global law firm White & Case LLP has advised a buyer consortium led by Oceanpine Capital Inc. (Oceanpine Capital) on a go-private transaction involving LakeShore Biopharma Co., Ltd (LakeShore Biopharma).
The buyer consortium, which consists of Oceanpine Capital and certain existing LakeShore Biopharma shareholders, will acquire all of the outstanding shares in LakeShore Biopharma that it does not own pursuant to certain merger agreement and ancillary agreements dated November 4, 2025.
LakeShore Biopharma is a global biopharmaceutical company which discovers, develops, manufactures and delivers new generations of vaccines and therapeutic biologics for infectious diseases and cancer.
The White & Case team was led by partner Alan Bao (Beijing) and included associates Qianru Hong, Ryann An (both Shanghai), Zixie Zhu (Beijing) and Paul Qu (Hong Kong).
Press contact
For more information please speak to your local media contact.